Market segmentation
By Offering
- Systems
- Software
- Services
By Technology
- External Beam Radiotherapy
- Internal Beam Radiotherapy
- Brachytherapy
By Application
- EBRT Applications
- IBRT
- Brachytherapy Applications
By End User
- Hospitals
- Standalone Radiotherapy Centers
Regional analysis
Asia Pacific is projected to register the highest CAGR of 7.1% during the forecast period, driven by rising cancer prevalence, accelerating healthcare infrastructure investment, and government spending increases in lower-middle-income countries. North America and Europe maintain substantial absolute market size but face mature adoption curves and slower percentage growth as advanced radiotherapy infrastructure reaches saturation. LAMEA regions present emerging demand driven by industrialization and rising per-capita treatment capacity, though infrastructure constraints limit immediate penetration rates. Geographic expansion reflects divergent healthcare spending patterns, cancer incidence trends, and equipment adoption cycles across developed, developing, and least-developed healthcare systems.
Opportunities to watch
Rising cancer prevalence in China, India, Brazil, and Mexico creates substantial demand for radiotherapy infrastructure and treatment capacity. Government health spending in low-income countries is projected to grow 14% between 2024 and 2030, while lower-middle-income countries will see 17% growth, enabling expansion of oncology facilities and equipment procurement. Medical tourism, reduced treatment costs relative to developed economies, and accelerating adoption of AI-enabled radiotherapy and CyberKnife radiosurgery platforms provide additional revenue channels for manufacturers targeting emerging healthcare systems.
Southeast Asia, Latin America, and parts of Africa represent underserved markets where industrialization and rising living standards are generating demand for radiotherapy solutions and oncology infrastructure that currently remains largely unmet.
Leading companies
- Siemens Healthineers AG
- Elekta
- Accuray Incorporated
- IBA Worldwide
- ViewRay Inc
- D capabilities
- Eastern Europe
- LATAM to improve access to oncology treatment
For complete market sizing, forecasts, and competitive intelligence, read the full Radiotherapy Market — covering growth drivers, regional analysis, and leading company profiles through 2033.